CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

HIBERIX

RegulatoryapprovedHIBERIXPositive
AI Analysis

Summary

HIBERIX is an FDA-approved vaccine for active immunization against invasive disease caused by Haemophilus influenzae type b in children aged 6 weeks through 4 years.

Outcome Details

Approved for use in children aged 6 weeks through 4 years (prior to fifth birthday)

Importance:3/10
Sentiment:
0.30
vaccinepediatricHaemophilus influenzae type bimmunization

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on July 8, 2026 3:06 PM

Read Original